Specific immunotherapy for latex allergy

To evaluate the efficacy of subcutaneous and sublingual immunotherapy for type I latex allergy in reducing allergen sensitivity following latex exposure.

To evaluate the safety of subcutaneous and sublingual immunotherapy for type I latex allergy.

This is a protocol.

Share/Save